Amphiphilic polysaccharide derivative carrier for targeting tumor new blood vessels as well as preparation and application of pharmaceutical composition of amphiphilic polysaccharide derivative carrier

A technology of tumor neovascularization and amphiphilic polysaccharides, which is applied in the direction of anti-tumor drugs, drug combinations, and medical preparations of non-active ingredients, etc., which can solve the problems of low drug uptake rate, poor targeting of tumor blood vessels, and side effects And other issues

Active Publication Date: 2015-10-14
CAPITAL UNIVERSITY OF MEDICAL SCIENCES
View PDF4 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

First of all, the tumor blood vessel targeting of the drug is not strong. While acting on tumor blood vessels, it will also have an effect on normal tissues and cells, resulting in serio

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Amphiphilic polysaccharide derivative carrier for targeting tumor new blood vessels as well as preparation and application of pharmaceutical composition of amphiphilic polysaccharide derivative carrier
  • Amphiphilic polysaccharide derivative carrier for targeting tumor new blood vessels as well as preparation and application of pharmaceutical composition of amphiphilic polysaccharide derivative carrier
  • Amphiphilic polysaccharide derivative carrier for targeting tumor new blood vessels as well as preparation and application of pharmaceutical composition of amphiphilic polysaccharide derivative carrier

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0062] Example 1: Preparation of Esbp-disulfide-acetylated hyaluronic acid

[0063] 0.1mmol of hyaluronic acid, 1mmol of 2-aminoethanethiol, 1mmol of EDC and 1mmol of NHS were dissolved in formamide. After 24 hours of reaction, the hyaluronic acid intermediate was precipitated with acetone, filtered and dialyzed with distilled water for 72 hours (MWCO=3500), frozen Dry to obtain the hyaluronic acid intermediate of free one end mercapto group.

[0064] Dissolve 0.4mmol Esbp peptide and 0.1mmol hyaluronic acid intermediate in formamide, oxidize in natural air, and react for 24h. After the reaction was completed, it was dialyzed with excess distilled water for 72 hours (MWCO=3500), and freeze-dried to obtain the Esbp-disulfide-acetylated hyaluronic acid derivative carrier.

Embodiment 2

[0065]Embodiment 2: Preparation of Esbp-disulfide-propionylated chitosan

[0066] 0.1mmol chitosan was dissolved in a mixed solvent of water and methanol (v / v=1:1), 1mmol 3-mercaptopropionic acid, 0.5mmol EDC and 0.5mmol HOBt were added, reacted for 8h, methanol was removed by rotary evaporation, and distilled water was dialyzed for 72h (MWCO= 3500), freeze-dried to obtain the chitosan intermediate of a free end sulfhydryl.

[0067] 0.5mmol Esbp peptide and 0.1mmol chitosan intermediate were dissolved in a mixed solvent of water and methanol (v / v=1:1), ammonia water was used to adjust the pH value to 8.0, potassium ferricyanide (0.2mmol) aqueous solution was added dropwise, Reaction at room temperature for 2h. After the reaction was completed, the methanol was removed by rotary evaporation, dialyzed in distilled water for 72 hours (MWCO=3500), and freeze-dried to obtain the Esbp-disulfide-propionylated chitosan derivative carrier.

Embodiment 3

[0068] Example 3: Preparation of Esbp-disulfide-acetylated chondroitin sulfate

[0069] 0.1mmol of chondroitin sulfate, 1mmol of 2-aminoethanethiol, 0.5mmol of EDC and 0.5mmol of DMAP were dissolved in formamide, and after 12 hours of reaction, the chondroitin sulfate intermediate was precipitated with acetone, suction filtered and dialyzed with distilled water for 72 hours (MWCO=3500 ), freeze-dry to obtain the chondroitin sulfate intermediate of free one-end sulfhydryl.

[0070] Dissolve 0.2mmol Esbp and 0.1mmol chondroitin sulfate intermediate in a mixed solvent of N,N-dimethylformamide and water, add iodine solution (0.2mmol) dropwise for oxidation, and react for 30min. After the reaction, use excess acetone to precipitate, filter and vacuum dry to obtain the Esbp-disulfide-acetylated chondroitin sulfate derivative carrier.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention relates to an amphiphilic polysaccharide derivative carrier for targeting tumor new blood vessels. According to the derivative, a polysaccharide skeleton is coupled with functional polypeptide targeting E-selectin by virtue of a disulfide bond to ensure that polysaccharide has amphipathy, and is assembled into nano particles for targeting the tumor new blood vessels after carrying an antitumor drug or a tumor new blood vessel inhibitor in an aqueous medium. The nano particles deliver medicines to the tumor new blood vessels in an active targeting manner by virtue of the high affinity between the functional polypeptide targeting the E-selectin and the E-selectin on the surface of the tumor new blood vessels, then a disulfide bond connecting arm can be specifically degraded by a strong reducing environment in endothelial cells of the tumor new blood vessels to cause that the functional polypeptide targeting the E-selectin is separated from polysaccharide, and the medicines are quickly released to treatment target points, so that the concentration of free medicines at tumor new blood vessel parts can be significantly improved and the antitumor curative effect is enhanced. An auxiliary material can be used as a carrier for water-insoluble, indissolvable or amphiphilic antitumor drugs and the tumor new blood vessel inhibitor, and is administrated by injecting into blood vessels or muscles, or is administrated orally or externally. The amphiphilic polysaccharide derivative carrier provided by the invention is simple in preparation method, mature in process and suitable for large-scale production.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, and relates to an amphiphilic polysaccharide derivative targeting neovascularization of tumors as a drug carrier, and also relates to a preparation method and application of the carrier. Background technique [0002] Malignant tumors are an important disease that endangers human health in the world. Although the understanding of tumor cell biology and genetics has reached the level of molecular biology, and new treatment concepts and methods continue to emerge, the overall cure rate of malignant tumors is still low. . American scholar Judah Folkman reported that tumor growth depends on the formation of new blood vessels. During the growth of tumor tissue, new blood vessel formation is often induced, that is, the process of forming new capillaries from existing blood vessels. Studies have shown that the diameter or thickness of the tumor tissue block reaches 1-2mm 3 At this time, if th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K47/42A61K47/36A61K9/14A61K9/19A61P35/00A61K31/337
Inventor 李静韩晓凤龚慕辛李潇
Owner CAPITAL UNIVERSITY OF MEDICAL SCIENCES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap